Carol Gallagher to join the Metastatix, Inc. as Chief Executive Officer

Life Science Partner recruits former SVP, Corporate Development and Commercial Affairs of Anadys Pharmaceuticals, Inc.

Life Science Partner announces the recruitment of Carol Gallagher, an experienced biotechnology and pharmaceutical executive, to Metastatix, Inc.  Metastatix is an emerging pharmaceutical company developing and commercializing effective, convenient and safe small-molecule drugs for a broad portfolio of indications including cancer, HIV infection and inflammation.  The company’s initial focus has been on the CXCR4 receptor, a critical mediator of cellular and chemical trafficking.

Gallagher was Senior Vice President, Corporate Development and Commercial Affairs for Anadys Pharmaceuticals, a biopharmaceutical company committed to the development and commercialization of small-molecule medicines for the treatment of hepatitis C virus (HCV) infection and cancer, where she was responsible for commercial and portfolio leadership, business development and strategic planning.  Earlier, Gallagher was Vice President of Sales, Marketing and Product Planning for the CancerVax Corporation where she successfully led all aspects of commercial planning and product development for the launch of a Phase III oncology product and the alliance with Serono Pharmaceuticals.  Throughout her career, Gallagher held leadership positions at Biogen Idec, Agouron/Pfizer, Amgen and Eli Lilly and Company.

“Carol is a well networked and experienced marketing and commercialization executive in the field of biotechnology drug development for oncology markets,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “We welcome her to our hometown of Atlanta where she’ll lead Metastatix’ broad portfolio platform through all phases of building a world class biotechnology company.”

Metastatix recently raised a $35M Series B round from a nationally recognized group of venture investors including Frazier Healthcare Ventures, HIG Ventures, SROne, Aruna, and Georgia Ventures Partners.

Gallagher earned her undergraduate degree from the College of Arts and Sciences at Vanderbilt University and received her Doctor of Pharmacy and Bachelor of Science degrees from the University of Kentucky.